戻る
West Pharmaceutical Services Inc (WST) 収入
WST 株価推移チャート
WST 収入
West Pharmaceutical Services Inc
$254.8
0.81%
$2.06
終値： Apr 02, 16:00:00 GMT-4
$254.8
0%
$0
アフターマーケット：Apr 02, 20:00:00 GMT-4
最新の利益結果: Q4 '25
報告済み: 2026-02-12
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
WSTの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
West Pharmaceutical Services Inc WSTの前四半期の収益はどうでしたか？
West Pharmaceutical Services Incの収益見積もりはいくらですか？
West Pharmaceutical Services Incの収益品質スコアはどれくらいですか？
West Pharmaceutical Services Incはいつ収益を報告しますか？
West Pharmaceutical Services Incの予想収益はいくらですか？
West Pharmaceutical Services Incは収益予想を上回りましたか？
主要データ
前終値
$252.74
始値
$250.82
当日レンジ
$249.59 - $258.24
52週レンジ
$187.43 - $322.34
取引高
466.5K
平均取引高
1.0M
配当利回り
0.37%
1株当たり利益(TTM)
6.79
時価総額
$18.3B
WSTとは何ですか？
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.